A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder	Recruiting	Phase 2	2026-08-12		NCT07037901

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Inmagene LLC	2

30 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Inmagene Site 1	Lancaster	United States	2
Inmagene Site 10	Fargo	United States	2
Inmagene Site 11	Woodbury	United States	2
Inmagene Site 12	Anderson	United States	2
Inmagene Site 13	Mississauga	Canada	2
Inmagene Site 14	Montreal	Canada	2
Inmagene Site 15	Surrey	Canada	2
Inmagene Site 16	Saskatoon	Canada	2
Inmagene Site 17	Greater Sudbury	Canada	2
Inmagene Site 18	North Bay	Canada	2
Inmagene Site 19	Ocala	United States	2
Inmagene Site 2	Rolling Meadows	United States	2
Inmagene Site 20	Charlotte	United States	2
Inmagene Site 21	New York	United States	2
Inmagene Site 22	Vancouver	Canada	2
Inmagene Site 23	Los Angeles	United States	2
Inmagene Site 24	Mitcham	Australia	1
Inmagene Site 25	Woden	Australia	1
Inmagene Site 26	Benowa	Australia	1
Inmagene Site 27	Carlton	Australia	1
Inmagene Site 28	Liverpool	Australia	1
Inmagene Site 29	Hamilton	New Zealand	1
Inmagene Site 3	Portland	United States	2
Inmagene Site 30	Auckland	New Zealand	1
Inmagene Site 4	Tampa	United States	2

Clinical trials